Search

Your search keyword '"Harigai, Masayoshi"' showing total 1,067 results

Search Constraints

Start Over You searched for: Author "Harigai, Masayoshi" Remove constraint Author: "Harigai, Masayoshi"
1,067 results on '"Harigai, Masayoshi"'

Search Results

3. Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study

5. Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study

7. Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study

8. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial

9. Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis

12. Factors contributing to the improvement in J-HAQ after 3 years of treatment with abatacept in biologic-naïve rheumatoid arthritis patients: Interim results of a long-term, observational, multicentre study in Japan (ORIGAMI)

13. Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study

14. Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort study

16. ‘Not at target’: prevalence and consequences of inadequate disease control in systemic lupus erythematosus—a multinational observational cohort study

18. Late-onset rheumatoid arthritis registry study, LORIS study: study protocol and design

19. Low disease activity of microscopic polyangiitis in patients with anti-myosin light chain 6 antibody that disrupts actin rearrangement necessary for neutrophil extracellular trap formation

20. Systematic review for the treatment of older rheumatoid arthritis patients informing the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis.

22. The real-world clinical decisions of physicians in the management of Takayasu arteritis and giant cell arteritis in Japan: A cross-sectional web-questionnaire survey

23. Comparison Of Attainment And Protective Effects Of Lupus Low Disease Activity State In Patients With Newly Diagnosed Versus Established SLE.

25. Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study

26. Expansion of HLA‐DR+ Peripheral Helper T and Naïve B cells in Anti‐Citrullinated Protein Antibody‐Positive Subjects At‐Risk for Rheumatoid Arthritis

27. 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease

31. Real-world clinical decisions of physicians in the management of Takayasu arteritis and giant cell arteritis in Japan: A cross-sectional web questionnaire survey.

32. Expansion of HLA‐DR Positive Peripheral Helper T and Naive B Cells in Anticitrullinated Protein Antibody‐Positive Individuals At Risk for Rheumatoid Arthritis.

33. Seasonal fluctuation of serum Krebs von den Lungen‐6 levels in systemic sclerosis‐associated interstitial lung disease.

34. Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis with polyangiitis: The 2023 update – secondary publication

35. Evaluation of Ministry of Health, Labour and Welfare diagnostic criteria for antineutrophil cytoplasmic antibody–associated vasculitis compared to ACR/EULAR 2022 classification criteria.

36. Establishing clinical remission criteria for giant cell arteritis: Results of a Delphi exercise carried out by an expert panel of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis

38. Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort study

40. A preliminary survey of rheumatologists on the management of late-onset rheumatoid arthritis in Japan

41. Effectiveness and safety of treat-to-target strategy for methotrexate-naïve rheumatoid arthritis patients >75 years of age

47. Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study

48. Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study

49. Impact of interstitial lung disease on clinical remission and unfavourable events of rheumatoid arthritis: results from the IORRA cohort.

50. Interleukin‐18 as a crucial cytokine in chronic arthritic systemic juvenile idiopathic arthritis.

Catalog

Books, media, physical & digital resources